ArticleThe oncologist2026

Efficacy of perioperative pembrolizumab for triple-negative breast cancer with apocrine feature or metaplastic carcinoma.

Nobuyuki Takahashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.